The use of luteinizing hormone releasing hormone agonists administrated to patients with prostate cancer predisposes to dementia: a population-based analysis

Category Primary study
JournalJ Urol
Year 2009
This article has no abstract
Epistemonikos ID: 3cc24404ad78bbe5f53a5ba84f223c6fe2225e7e
First added on: Nov 28, 2017